Citizens National Bank Trust Department’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Buy
1,809
+3
+0.2% +$3.06K 0.32% 75
2026
Q1
$1.66M Buy
1,806
+90
+5% +$91.2K 0.28% 88
2025
Q4
$1.84M Buy
1,716
+10
+0.6% +$9.56K 0.32% 86
2025
Q3
$1.3M Buy
1,706
+639
+60% +$476K 0.23% 101
2025
Q2
$832K Buy
1,067
+1,025
+2,440% +$796K 0.17% 112
2025
Q1
$34.7K Buy
42
+27
+180% +$22.5K 0.01% 266
2024
Q4
$11.6K Hold
15
﹤0.01% 298
2024
Q3
$13.3K Hold
15
﹤0.01% 286
2024
Q2
$13.6K Sell
15
-5
-25% -$4K ﹤0.01% 284
2024
Q1
$15.6K Sell
20
-20
-50% -$14.2K ﹤0.01% 273
2023
Q4
$23.3K Hold
40
0.01% 244
2023
Q3
$21.5K Sell
40
-10
-20% -$5.15K 0.01% 247
2023
Q2
$23.4K Buy
+50
New +$21K 0.01% 250

Other funds holding LLY

Citizens National Bank Trust Department's LLY Position: Q2 2026 in Review

Citizens National Bank Trust Department increased its Eli Lilly (LLY) stake by 0.17% in Q2 2026, buying an estimated $3.06K and bringing the position to 1,809 shares worth $2.17M. The position accounts for 0.32% of the portfolio, ranked #75.

Citizens National Bank Trust Department first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 2,925 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Citizens National Bank Trust Department held 1,809 shares of Eli Lilly worth $2.17M as of Q2 2026.
  • Citizens National Bank Trust Department bought 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
  • Eli Lilly made up 0.32% of Citizens National Bank Trust Department's portfolio in Q2 2026, its #75 holding.
  • Citizens National Bank Trust Department first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 2,925 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Citizens National Bank Trust Department's 13F filing for Q2 2026, filed 22 Jul 2026.